1,2200
22-ноября-24 15:44:58
15 мин. задержка
Акции
+0,0300
+2,52%
Сегодняшний диапазон
1,1700 - 1,2300
ISIN
N/A
Источник
NASDAQ
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
12 июн 2023 08:15:00 Источник Nasdaq GlobeNewswire
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer
01 июн 2023 08:10:00 Источник Nasdaq GlobeNewswire